Interní Med. 2011; 13(9): 329-333

Vitamin D and frailty

prof.MUDr.Hana Matějovská Kubešová, CSc.1, MUDr.Jana Tůmová2, MUDr.Vlasta Polcarová1, MUDr.Hana Meluzínová1
1 Klinika interní, geriatrie a praktického lékařství LF MU a FN Brno
2 Oddělení klinické biochemie FN Brno

Frailty syndrome comprises not only emerging fractures caused by instability and falls, but complex of pathologies as frequent organ

decompensations, infective complications, psychical problems and rapid cognitive decline accelerating the appearance of disability and

dependency of seniors. Vitamin D as one of liposolubile vitamins was related to children age and skeleton at the clinical practice until

now. There is lot of new information considering rather more complicated connection of vitamin D into many functions of human body

during last years. This review shows actual information about relationship between vitamin D and organ systems and their disturbances.

Long term low level of vitamin D potentiates cognitive deterioration in elderly, influences the mood up to depression appearance. The

influence of vitamin D on imunity system and cancerogenesis appears to be of high importance too. From the senior´s independence

point of view the relationship between vitamin D and sarcopenia is very important especially in connection with osteoporosis prevention

– the way how to reduce the danger of falls and osteoporotic fractures. Autoimmune diseases and diabetes mellitus are mentioned

at the end of the review.

Keywords: frailty, vitamin D, bone, muscle, sarcopenia, cognitive functions, depression, cancer, autoimunity, diabetes mellitus

Published: September 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matějovská Kubešová H, Tůmová J, Polcarová V, Meluzínová H. Vitamin D and frailty. Interní Med. 2011;13(9):329-333.
Download citation

References

  1. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2010.
  2. Bischoff-Frrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: s meta-analysis of randomised controlled trials. BMJ 2009; 339: b3692. Go to original source... Go to PubMed...
  3. Dietary suplement sheet: Vitamin D. Office of Dietary Supplements. National Institute of Health 2011; 2: 1-15.
  4. Kiebzak GM, Moore NL, Margolis S, et al. Vitamin D status of patients admitted to a hospital rehabilitation unit: relationship to function and progress. Am J Phys Med Rehabil. 2007; 86(6): 435-445. Go to original source... Go to PubMed...
  5. Matějovská Kubešová H. Problematika vitaminu D u seniorů. Gerontologický kongres Hradec Králové, prosinec 2010, sborník abstrakt.
  6. Cranney A, Horsley T, O´Donnel S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess 2007; 158: 1-235.
  7. Ovesen L, Brot C, Jakobsen J. Food contents and biological activity of 25-hydroxyvitamin D: a vitamin D metabolite to be reckoned with? Ann Nutr Metab 2003; 47: 107-113. Go to original source... Go to PubMed...
  8. Oudshoom C, Matrace Raso FU, van der Velde N, et al. Higher vitamin D serum levels are associated with better cognitive test performance in patients with Alzheimer´s disease. Dement Geriatr Cogn Disord 2008; 25(6): 539-543. Go to original source... Go to PubMed...
  9. Evatt ML, Delong MR, Kazai N, et al. Prevalence of vitamin D insufficiency in patiens with Parkinson disease and Alzheimer diasease. Arch Neurol 2008; 65(10): 1348-1352. Go to original source... Go to PubMed...
  10. Gezen-Ak D, Durzun E, Ertan T, et al. Association between vitamin D receptor gene polymorphism and Alzheimer´s disease. Tohoku J Exp Med 2007; 212(3): 275-282. Go to original source... Go to PubMed...
  11. Fujita T. Alzheimer disease and kalcium. Clin Kalcium 2004; 14(1): 103-105.
  12. Stumpf WE, Privette TH. Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 in ethiology and therapy of seasonal affective disorders and other mental processes. Psychopharmacology 1989; 97(3): 285-294. Go to original source... Go to PubMed...
  13. Landsdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 1998; 135(4): 319-323. Go to original source... Go to PubMed...
  14. Kenny AM, Biskup B, Robbins B, et al. Effect of vitamin D supplementetion on strength, physical function and health perception in older, community-sdwelling men. J Am Geriatr Soc 2003; 51(12): 1762-1767. Go to original source... Go to PubMed...
  15. Lambert GW, Reid C, Kaye DM, et al. Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002; 360: 1840-1842. Go to original source... Go to PubMed...
  16. Capiati DA, Rossi AM, Piccoto D, et al. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha, 25 (OH) 2-vitamin D3 in MCF-7 breast cancer cells. J Cell Biochem 2004; 93(2): 384-397. Go to original source... Go to PubMed...
  17. Field S, Newton-Bishop JA. Melanoma and vitamin D. Mol Oncol. 2011, 3. Go to original source... Go to PubMed...
  18. Peppone L, Rickles A, Huston A, et al. The Association between Prognostic Demographic and Tumor Characteristics of Breast Carcinomas with Serum 25-OH Vitamin D Levels. Cancer Epidemiol Biomarkers Prev. 2011; 20(4): 717. Go to original source...
  19. Berwick M. Can UV Exposure Reduce the Mortality? Cancer Epidemiol Biomarkers Prev. 2011; 20(4): 582-584. Go to original source... Go to PubMed...
  20. Adams SV, Newcomb PA, Burnett-Hartmann AN, et al. Circulating 25-Hydroxyvitamin-D and Risk of Colorectal Adenomas and Hyperplastic Polyps. Nutr Cancer. 2011, 23:1. Go to original source... Go to PubMed...
  21. Lee JE, LI H, Chan AT, et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila). 2011 Mar 23. Go to original source... Go to PubMed...
  22. Hayes CE, Nashold FE Spach KM, et al. The immunological fuctions of the vitamin D endocrine system. Cell Mol Biol 2003; 49(2): 277-300.
  23. Hansdottir S, Monick MM. Vitamin D effects on lung immunity and respiratory diseases. Vitam Horm. 2011; 86: 217-237. Go to original source... Go to PubMed...
  24. Hewison M. Vitamin D and innate and adaptive imunity. Vitam Horm. 2011; 86: 23-62. Go to original source... Go to PubMed...
  25. Herr C, Greulich T, Konzula RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancor. Respir Res. 2011; 12(1): 31. Go to original source... Go to PubMed...
  26. Morelli S, Buitrago C, Vasquez G, et al. Involvement of tyrosine kinase activity in 1alpha, 25 (OH) 2-vitamin D3 signal transduction in skeletal muscle cells. J Biol Chem 2000; 275(46): 36021-36028. Go to original source... Go to PubMed...
  27. Scott D, Blizzard L, Fell J, et al. A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol 2010; 73(5): 581-587. Go to original source... Go to PubMed...
  28. Bauer MJ, Kaiser JM, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dis Assoc 2008; 9(8): 545-551. Go to original source... Go to PubMed...
  29. Verchueren SM, Bogaerts A, Deleclusen C, et al. The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J Bone Miner Res 2011; 26(1): 42-49. Go to original source... Go to PubMed...
  30. Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010; 11(6): 391-396. Go to original source... Go to PubMed...
  31. Reid IR, Bolland MJ, Avenell A, et al. Cardiovascular effects of calcium supplementation. Osteoporos Int. 2011, 16. Go to original source... Go to PubMed...
  32. Cutolo M, Plebani M, Schoenfeld Y, et al. Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm. 2011; 86: 327-351. Go to original source... Go to PubMed...
  33. Bikkle DD. Vitamin D regulation of immune function. Vitam Horm. 2011; 86: 1-21. Go to original source... Go to PubMed...
  34. Devaray S, Yun JM, Duncan-Staley CR, et al. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am J Clin Pathol. 2011; 135(3): 429-433. Go to original source... Go to PubMed...
  35. Bizzari C, Pittoco D, Napoli N, et al. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care. 2010; 33(9): 1962-1963. Go to original source... Go to PubMed...
  36. Aljabri KS, Bogari SA, Khan MJ. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med. 2010; 30(6): 454-458. Go to original source... Go to PubMed...
  37. Hypponen E. Vitamin D and increasing incidence of type I diabetes mellitus - evidence for an association? Diabetes obes metab 2010; 12(9): 737-743. Go to original source... Go to PubMed...
  38. Cavalier E, Delanaye P, Souberbielle JC, et al. Vitamin D and type 2 diabetes mellitus: Where do we stand? Diabetes Metab. 2011 Feb 21. Go to original source... Go to PubMed...
  39. Yiu YF, Chan YH, Yiu KH, et al. Vitamin D Deficiency Is Associated with Depletion of Circulating Endothelial Progenitor Cells and Endothelial Dysfunction in Patients with Type 2 Diabetes. J Clin Endocrinol Metab. 2011, 16. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.